
Rose Biosolutions is the leading provider of advanced manufacturing capabilities across the cell and gene therapy space. Rose Biosolutions delivers end-to-end advanced therapy solutions for clients across plasmid DNA, viral vector, and cell therapy capabilities, as well as the ability to deliver the cellular materials that research and advanced therapies depend on.
Investment Details
- Initial Investment Date: May 2026
- GI Role: Sole Investor
- Status: Current

